Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Miyakoshi J et al. | 1994 | intact cell/cell culture, human leukemia cell lines (HL60RG, CCRF-CEM9), GM0637 cells (normal human fibroblast cell line), TAT2SF cells (human Louis-Bar syndrome fibroblast cell line) | magnetic field, 50/60 Hz, also other exposures without EMF | 400 mT |
West RW et al. | 1994 | intact cell/cell culture, JB6 Cl 41 cells (BALB/c mouse normal epithelial cell line) | magnetic field, 50/60 Hz | 1.1 mT |
Cossarizza A et al. | 1993 | intact cell/cell culture, human peripheral blood mononuclear cells | electric field, magnetic field, signals/pulses, 50/60 Hz | 2.5 mT |
Revoltella RP et al. | 1993 | intact cell/cell culture, Friend erythroleukemia cell line (line 3BM-78, clone H19 from line 5-86, line 707M, clone F4-1 from line F4-N) | magnetic field, 50/60 Hz | 200 µT |
Paradisi S et al. | 1993 | intact cell/cell culture, K562 cells (human erythroleukemic cell line) | magnetic field, 50/60 Hz | 2.5 mT |
Zwingelberg R et al. | 1993 | animal, rat/Wistar, whole body | magnetic field, 50/60 Hz | 30 mT |
Liburdy RP et al. | 1993 | intact cell/cell culture, MCF-7 cells (melatonin-sensitive breast cancer cell line) | magnetic field, 50/60 Hz, co-exposure | 0.19–1.195 µT |
Schimmelpfeng J et al. | 1993 | intact cell/cell culture, SV40-swiss-3T3 cells (mouse fibroblast cell line) | electric field, magnetic field, 50/60 Hz | 2 mT |
Cain CD et al. | 1993 | intact cell/cell culture, C3H 10T1/2 and UV/TDT10e (10e) cells (mouse fibroblast cells) | magnetic field, 50/60 Hz, co-exposure | 0.1 mT |
Fiorani M et al. | 1992 | intact cell/cell culture, human myeloid leukemia cell line (K-562) | electric field, magnetic field, 50/60 Hz | 0.2–200 µT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.